Cutaneous and ophthalmic signs as a clue to early diagnosis of severe neurofibromatosis type 2: Report of a novel mutation that predicts this poor prognosis

导出原文传递

翻译打印收藏纠错

作者： Casado-Verrier,B. ^[1] ; Feito-Rodriguez,M. ^[2] ; Noval,S. ^[3] ; Martínez-Glez,V. ; Lapunzina,P. ; DeLucas-Laguna,R.

作者单位： Department of Ophthalmology, Hospital la Paz, Madrid, Spain ^[1] Department of Genetics, Hospital la Paz, Madrid, Spain ^[2] Department of Dermatology, Hospital la Paz, Paseo de la Castellana, 261, Madrid, 28034, Spain ^[3]

关键词 End-stage renal disease Janus kinase inhibitor Pharmacokinetics Renal impairment Tofacitinib

发布时间 2014-09-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical and experimental dermatology

2014年39卷4期

557-559页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cutaneous and ophthalmic signs as a clue to early diagnosis of severe neurofibromatosis type 2: Report of a novel mutation that predicts this poor prognosis

Clinical and experimental dermatology

相似文献

Clinical and experimental dermatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cutaneous and ophthalmic signs as a clue to early diagnosis of severe neurofibromatosis type 2: Report of a novel mutation that predicts this poor prognosis

Clinical and experimental dermatology

相似文献

Clinical and experimental dermatology

相关期刊

检索历史清除